GHK-Cu 50mg - Third-Party Test Results

Manufacturer: LeoLab™

Sample: GHK-Cu 50mg

Date: 25 MAR 2025

On March 25, 2025, an independent third-party analysis of LeoLab’s GHK-Cu 50mg peptide was conducted by Janoshik Analytical, a trusted name in pharmaceutical testing. The test was registered under Task Number 60437 and evaluated Batch G60099 for purity, identity, and mass content.

Test Summary:

  • Peptide Tested: GHK-Cu

  • Batch Number: G60099

  • Nominal Quantity: 50 mg

  • Measured Mass: 49.01 mg

  • Purity: 99.961%

Review:

The test results from Janoshik Analytical confirm exceptional purity, with the peptide achieving 99.961%, which is well above industry standards and indicative of high-quality synthesis and purification processes. This level of purity is particularly significant for research applications requiring precision and consistency.

The measured mass of 49.01 mg also validates the labeling accuracy of the vial, ensuring researchers receive exactly what is advertised. Furthermore, the analysis confirmed the identity of the peptide, matching the expected molecular structure of GHK-Cu.

Purity 99.961%

The GHK-Cu 50mg sample from LeoLab (Batch G60099) underwent independent testing by Janoshik Analytical on March 25, 2025. The analysis confirmed an exceptional purity of 99.961%, indicating a highly refined peptide with minimal impurities—ideal for precise and reliable research applications.

Mass 49.01 mg

The GHK-Cu 50mg sample from LeoLab (Batch G60099) was tested by Janoshik Analytical on March 25, 2025, and confirmed to have a measured mass of 49.01 mg. This result verifies the product's labeling accuracy and consistency, ensuring researchers receive the intended dosage.
GHK-CU 50mg test results
 Verify Report
Category: GHK-CU Tests

More test results

Leave a Reply